Kämmerling, Nina https://orcid.org/0000-0002-3986-9737
Farnebo, Simon
Sandstedt, Mårten
Booij, Ronald
Persson, Anders
Tesselaar, Erik
Funding for this research was provided by:
Region Östergötland (RÖ-965126)
Article History
Received: 5 December 2024
Accepted: 14 April 2025
First Online: 1 May 2025
Declarations
:
: The study was approved by the Swedish Ethical Review Authority (Dnr. 2021-02034).
: Patients eligible to participate received oral and written information about the study and were given the option to decline.
: SF provides consulting services for Swemac Innovation AB. RB has been, since February 2025, employed as Scientific Product Manager at Siemens Healthineers. The remaining authors declare no conflicts of interest.